CLB (Core Laboratories) Risk Assessment

View and export this data going back to 1995. Start your Free Trial

What is Core Laboratories Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Core Laboratories is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of Core Laboratories's Risk Assessment

For the Oil & Gas Equipment & Services subindustry, Core Laboratories's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Core Laboratories's Risk Assessment Distribution in the Oil & Gas Industry

For the Oil & Gas industry and Energy sector, Core Laboratories's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Core Laboratories's Risk Assessment falls into.

Save Embed

;

Save Embed

;

Core Laboratories (NYSE:CLB) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Core Laboratories Risk Assessment Related Terms

Thank you for viewing the detailed overview of Core Laboratories's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Core Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Energy » Oil & Gas » Core Laboratories Inc (NYSE:CLB) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

HJ1:Germany

Address

6316 Windfern Road, Houston, TX, USA, 77040

Website

https://www.corelab.com

Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.

Executives

Katherine Murray	director	6316 WINDFERN ROAD, HOUSTON TX 77040
Mark Damian Tattoli	officer: SVP, Gen Counsel & Secretary	C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Kwaku Temeng	director	C/O CORE LABORATORIES LP, 2216 SHERIDAN STREET, HOUSTON TX 77002
Gwendolyn Schreffler	officer: SVP	C/O CORE LABORATORIES LP, 6316 WINDFERN ROAD, HOUSTON TX 77040
Harvey Robert Klingensmith	director	P.O. BOX 131144, HOUSTON TX 77219-1114
Van Dijken Eeuwijk Monique	director	P.O. BOX 129, BILTHOVEN P7 3720 AC
Jan Willem Sodderland	director	DUINDISTEL 89, NOORDWIJK P7 2202 DE
Goldman Sachs Group Inc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Goldman Sachs & Co. Llc	10 percent owner	200 WEST STREET, NEW YORK NY 10282
Lawrence Bruno	officer: President	6316 WINDFERN ROAD, HOUSTON TX 77040
Mark F Elvig	officer: VP, Counsel & Secretary	6316 WINDFERN, HOUSTON TX 77040
Gregory Barry Barnett	director	853 MILWAUKEE STREET, DENVER CO 80206
Kevin Daniels	officer: CAO & Treasurer	6316 WINDFERN ROAD, HOUSTON TX 77040
Michael Straughen	director	68 RUBISLAW DEN NORTH, ABERDEEN X0 AB15 4AN
Martha Z. Carnes	director	6316 WINDFERN ROAD, HOUSTON TX 77040